⌘K
t
Reckitt Benckiser Group PLC's share consolidation became effective on 02 February 2026, with the admission of its new ordinary shares to the FCA's Official List and LSE trading occurring at 8:00 a.m. on the same date. As of 8:00 a.m. on 2 February 2026, the company's issued share capital consists of 674,005,752 ordinary shares of 10⁵⁄₁₂ pence each, with 29,252,346 ordinary shares held in treasury, resulting in a total of 644,753,406 voting rights.
| Date | 2 Feb 2026 |
| Time | 07:00:07 |
| Category | Capital structure |
| ID | 1944R |
RECKITT BENCKISER GROUP PLC
SHARE CONSOLIDATION EFFECTIVE AND TOTAL VOTING RIGHTS
Further to the announcement on 27 January 2026 that shareholder approval was granted at the General Meeting for a Special Dividend and associated Share Consolidation, Reckitt Benckiser Group plc (the "Company") is pleased to announce that the Company's Share Consolidation becomes effective today.
Admission of the Company's new ordinary shares to the ESCC category of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's Main Market for listed securities, is due to take place at 8.00 a.m. today.
The ISIN for the new ordinary shares is GB00BSZBP530.
As a result of the Share Consolidation and in accordance with the requirements of the FCA's Disclosure Guidance and Transparency Rule 5.6.1A, the Company hereby notifies the market that the Company's issued share capital as at 8.00 a.m. on 2 February 2026 will consist of 674,005,752 ordinary shares of 10⁵⁄₁₂ pence each. The Company will hold 29,252,346 ordinary shares in treasury. Therefore, the total number of voting rights in the Company as at 2 February 2026 will be 644,753,406. 644,753,406 may be used by shareholders and others with notification obligations as their denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Capitalised terms used but not otherwise defined in this announcement have the same meaning given to them in the Circular dated 7 January 2026.
For further Information:
Catheryn O'Rourke
Company Secretary
Tel. 01753 217 800
103-105 Bath Road, Slough SL1 3UH
Registered in England and Wales, No. 6270876
About Reckitt:
We make the products people trust to care for the ones they love. We are home to some of the world's best-loved consumer health and hygiene brands, including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet. Consumers are at the heart of everything we do. By creating innovative, science-backed solutions, we support people every day to live healthier lives.
Reckitt exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. This commitment goes beyond the products we make. Through our actions, we expand access to healthcare, education and economic opportunities. We support the planet by reducing waste, conserving resources and driving sustainable innovation.
We believe good health starts at home. With every action we take, we strive to make our consumers' lives easier, cleaner and healthier, to strengthen communities and to create a more sustainable future.
*Reckitt is the trading name of the Reckitt group of companies
Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108